Evaluation of the Motus GI CleanUp System During Screening Colonoscopy
1 other identifier
interventional
15
0 countries
N/A
Brief Summary
Motus GI is developing a single-use device that attaches to a standard colonoscope, thereby integrating colon cleansing, screening and treatment into one procedure. The device creates turbulence within the colon using water jets. The colon's fecal fluids are evacuated by the system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2013
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 21, 2013
CompletedFirst Posted
Study publicly available on registry
April 24, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedResults Posted
Study results publicly available
May 13, 2014
CompletedFebruary 14, 2017
April 1, 2014
10 months
April 21, 2013
February 4, 2014
December 26, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean of All Subjects Colon Segments BBPS>=2
Human colon has 3 segments and each segment can be scored 0 (unprepared colon) - 3 (clean colon). Summing all colon segments BBPS score of all participants dividing in the number of segments is expected to be \>=2.
Following the colonoscopic procedure- Up to 24 hours.
Study Arms (1)
Colonoscopy
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Subjects in the age range of 50-69 years
- Subjects who are considered for routine screening colonoscopy
- Subjects with BMI within the range of 18.5-30
- Subject is willing to sign informed consent form
You may not qualify if:
- History of GI diseases or history of Colorectal cancer (personal or family)
- Previous major abdominal surgeries
- Medical status ASA grater or equal to 3
- Acute GI symptoms, such as bleeding, unexplained weight loss, inflammatory bowel disease (IBD).
- Patients taking anticoagulants (e.g., Coumadin, Heparin, Clopidrogrel)
- Life-threatening condition
- Subjects who are unable or unwilling to cooperate with study procedures
- Severe Diverticula
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Results Point of Contact
- Title
- Medical Consultant
- Organization
- Motus GI Medical Technologies Ltd.
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- GT60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2013
First Posted
April 24, 2013
Study Start
April 1, 2013
Primary Completion
February 1, 2014
Study Completion
February 1, 2014
Last Updated
February 14, 2017
Results First Posted
May 13, 2014
Record last verified: 2014-04